Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response
0 sources
Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response
Summary
Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response is a doctoral thesis[1].
Key Facts
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response authored Francesco Mainini[2].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's instance of is recorded as doctoral thesis[3].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's publisher is recorded as OUR Archive[4].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's language of work or name is recorded as English[5].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's country of origin is recorded as New Zealand[6].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's publication date is recorded as +2016-00-00T00:00:00Z[7].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's main subject is recorded as MIS416[8].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's work available at URL is recorded as https://ourarchive.otago.ac.nz/handle/10523/6236[9].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's Handle ID is recorded as 10523/6236[10].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's title is recorded as Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response[11].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's copyright holder is recorded as Francesco Mainini[12].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's thesis submitted to is recorded as University of Otago[13].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's on focus list of Wikimedia project is recorded as NZThesisProject[14].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's copyright status is recorded as copyrighted[15].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's thesis committee member is recorded as Sarah Louise Young[16].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's thesis committee member is recorded as David Larsen[17].
- Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's thesis committee member is recorded as Michael Eccles[18].
Body
Designation and Status
Development of a new microparticle vaccine adjuvant with the ability to deliver peptides and siRNAs to Dendritic Cells in order to boost the immune response's instance of is recorded as doctoral thesis[3].